Use of a multibotanical (Nutrafem) for the relief of menopausal vasomotor symptoms: a double-blind, placebo-controlled study

Menopause : the Journal of the North American Menopause Society
Joan Tan GarciaCathryn W B Chan

Abstract

This study aimed to compare the efficacy and safety of a multibotanical (Nutrafem) with those of placebo for the treatment of menopausal vasomotor symptoms. In this phase III, double-blind, randomized, placebo-controlled study, 159 postmenopausal women experiencing at least 21 vasomotor symptoms per week were treated with Nutrafem (Bionutra Pte Ltd, Singapore) or a matched placebo for 12 weeks. Treatment outcome was evaluated by the change from baseline in the average weekly number of vasomotor symptoms. At the end of the study, Nutrafem reduced the number of vasomotor symptoms by 46% from baseline, and this is significantly superior to placebo (26% from baseline; P = 0.020). Forty-three percent of women taking Nutrafem experienced an at least 50% reduction in the number of symptoms compared with 6% of women taking placebo (P = 0.021; number needed to treat = 2.7). There were no group differences in adverse events, laboratory values, and gynecological data. Nutrafem is an effective botanical treatment for vasomotor symptoms in postmenopausal women.

References

Jun 1, 1994·Planta medica·M C RecioJ L Ríos
Mar 1, 1996·Maturitas·K Hill
Mar 8, 2000·Biological & Pharmaceutical Bulletin·Y LiS Takahashi
Mar 26, 2002·Climacteric : the Journal of the International Menopause Society·D C KnightJ A Eden
Jul 2, 2002·JAMA : the Journal of the American Medical Association·Deborah GradyUNKNOWN HERS Research Group
Jul 2, 2002·JAMA : the Journal of the American Medical Association·Stephen HulleyUNKNOWN HERS Research Group
Jul 19, 2002·JAMA : the Journal of the American Medical Association·Jacques E RossouwUNKNOWN Writing Group for the Women's Health Initiative Investigators
Oct 17, 2002·The Medical Journal of Australia·Peter W WhitingPaul Kerlin
Jun 5, 2003·JAMA : the Journal of the American Medical Association·Vered StearnsEric Dube
Jul 10, 2003·JAMA : the Journal of the American Medical Association·Jeffrey A TiceSteven R Cummings
Aug 9, 2003·The New England Journal of Medicine·JoAnn E MansonUNKNOWN Women's Health Initiative Investigators
Aug 21, 2003·Lancet·Valerie Beral, UNKNOWN Million Women Study Collaborators
Dec 11, 2003·Integrative Cancer Therapies·Tran Van HienNguyen Ba Duc
Feb 6, 2004·Annals of Internal Medicine·Jennifer S HaasKarla Kerlikowske
Apr 8, 2004·JAMA : the Journal of the American Medical Association·Heidi D Nelson
Apr 15, 2004·JAMA : the Journal of the American Medical Association·Garnet L AndersonUNKNOWN Women's Health Initiative Steering Committee
May 3, 2005·Obstetrics and Gynecology·Ruediger OsmersHans-Heinrich Henneicke-von Zepelin
Jun 25, 2005·The American Journal of Chinese Medicine·Cynthia LangDavid G Baker
Dec 24, 2005·Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology·Luis A HidalgoGlenda San Miguel
Apr 12, 2006·Menopause : the Journal of the North American Menopause Society·Alfredo Morabia, Michael C Costanza
May 4, 2006·JAMA : the Journal of the American Medical Association·Heidi D NelsonLinda Humphrey
Jun 20, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Barbara A PockajAbdul H Fauq
Oct 30, 2007·Maturitas·Rachel E WilliamsRichard V Clark
Jan 19, 2008·Climacteric : the Journal of the International Menopause Society·R E WilliamsR V Clark
Jan 19, 2008·Climacteric : the Journal of the International Menopause Society·D JoyP Duane
Apr 9, 2008·International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics·Hei-Jen JouWen-Huey Wu
Mar 5, 2009·Climacteric : the Journal of the International Menopause Society·A H MacLennanA W Taylor
Feb 16, 2010·Climacteric : the Journal of the International Menopause Society·N Senba, H Matsuo

❮ Previous
Next ❯

Citations

Feb 10, 2010·Menopause : the Journal of the North American Menopause Society·Katherine M Newton
Nov 10, 2011·Climacteric : the Journal of the International Menopause Society·P BouchardG Constantine
Sep 1, 2015·Endocrinology and Metabolism Clinics of North America·Maida Taylor
Oct 18, 2019·BJOG : an International Journal of Obstetrics and Gynaecology·S IliodromitiM Hickey
Jan 28, 2022·Menopause : the Journal of the North American Menopause Society·Kentaro MiyazakiMamoru Narukawa

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.